Found 202 matching trials
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV PHASE3 In 2012, the World Health Assembly (WHA) endorsed the proposed Polio Endgam...
Show More Location
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Kamalapur Field office, Lichubagan Rd
Learn More & Join Trial
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection PHASE2 NAPs have been previously shown to clear serum hepatitis B virus surface an...
Show More Location
Infectious Clinical Hospital (n.a. Toma Ciorba) Department 5
Learn More & Join Trial
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) PHASE3 To evaluate the immune response and the safety of a primary series schedule...
Show More Location
Multiple Locations
Learn More & Join Trial
TO Compare the Triple Drug Therapy and Dual Therapy . PHASE4 Study to Compare the Safety and Efficacy of Tacrolimus and Steroids in Comb...
Show More Location
Asan Medical Center
Learn More & Join Trial
Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment PHASE2 The primary objectives of this study are to evaluate the safety and tolerab...
Show More Location
University of Calgary Liver Unit - Heritage Medical Research Clinic
Learn More & Join Trial
4-Methylumbelliferone as a Treatment for Chronic HBV/HCV PHASE2 Open-label studies, anecdotal reports, and in vitro scientific research ind...
Show More Location
University Health Center Downtown "Brady/Green", 527 North Leona,
Learn More & Join Trial
Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. PHASE2 This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney Disease N/A The purpose of this study is to determine the durability of seroprotection ...
Show More Location
Clinical Research Associates of Tidewater
Learn More & Join Trial
Observational Study of Immune Response to Hepatitis B Childhood Booster N/A The UK immunisation guidelines recommend that children immunised with an ac...
Show More Location
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Churchill Hospital
Learn More & Join Trial
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants PHASE3 The purpose of this trial is to clinically confirm that the manufacturing p...
Show More Location
Multiple Locations
Learn More & Join Trial